Cargando…

Coronary Artery Disease Presentation and Its Association with Shortened Activated Partial Thromboplastin Time

Background: Standard coagulation screening tests are important constituents of basic examinations in clinical laboratories. There is no clear evidence of a relation between the type of clinical presentation and coagulation parameters in patients with suspected coronary artery disease. Methods: This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sotoudeh Anvari, Maryam, Tavakoli, Mojgan, Lotfi-Tokaldany, Masoumeh, Broumand, Mohammadali, Rezahosseini, Omid, Hakki-Kazzazi, Elham, Jalali, Arash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences, 2006- 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037630/ https://www.ncbi.nlm.nih.gov/pubmed/29997663

Ejemplares similares

Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values
por: Zhao, Ying, et al.
Publicado: (2011)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2018)

Anatomy of Atrioventricular Node Artery and Pattern of Dominancy in Normal Coronary Subject: A Comparison between Individuals with and without Isolated Right Bundle Branch Block
por: Kazemisaeid, Ali, et al.
Publicado: (2012)

The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy
por: Lapić, Ivana, et al.
Publicado: (2021)

A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention
por: Kassaian, Seyed-Ebrahim, et al.
Publicado: (2015)

High Perceived Stress May Shorten Activated Partial Thromboplastin Time and Lead to Worse Clinical Outcomes in Patients With Coronary Heart Disease
por: Yin, Han, et al.
Publicado: (2021)

Association between Traditional Risk Factors and Coronary Artery Ectasia: A Study on 10057 Angiographic Procedures among Iranian Population
por: Amirzadegan, Ali Reza, et al.
Publicado: (2014)

Relationship between Body Mass Index and Outcome of Elective Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2015)

Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients
por: Zhang, HuanRui, et al.
Publicado: (2022)

Relationship between calculated total antioxidant status and atherosclerotic coronary artery disease
por: Anvari, Maryam Sotoudeh, et al.
Publicado: (2016)

Surgical coronary revascularization in patients with COVID‐19; complications and outcomes: A retrospective cohort study
por: Ayati, Aryan, et al.
Publicado: (2022)

Response to Cardiac Resynchronization Therapy in Cardiomyopathy Patients with Right Bundle Branch Block
por: Zand, Sara, et al.
Publicado: (2023)

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
por: Samara, Evangelia, et al.
Publicado: (2021)

International normalized ratio and activated partial thromboplastin time testing
por: Chornenki, Nicholas L. J., et al.
Publicado: (2022)

The Impact of the COVID-19 Pandemic on Hospitalization Rates due to Prosthetic Valve Thrombosis
por: Jameie, Mana, et al.
Publicado: (2023)

Comparative analysis on characteristics of two activated partial thromboplastin time reagents
por: Yasui, Yutaro, et al.
Publicado: (2022)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
por: Santoro, Rita Carlotta, et al.
Publicado: (2023)

The Problem of the Lipoid Thromboplastins
por: Milstone, J. H.
Publicado: (1950)

Lipoid Thromboplastin and Trypsin
por: Milstone, J. H., et al.
Publicado: (1954)

Introducing the Tehran Heart Center's Premature Coronary Atherosclerosis Cohort: THC-PAC Study
por: Abbasi, Seyed Hesameddin, et al.
Publicado: (2015)

Factors Associated with Depressive Symptoms in Young Adults with Coronary Artery Disease: Tehran Heart Center's Premature Coronary Atherosclerosis Cohort (THC-PAC) Study
por: Abbasi, Seyed Hesameddin, et al.
Publicado: (2016)

Opium as a risk factor for early-onset coronary artery disease: Results from the Milano-Iran (MIran) study
por: Maino, Alberto, et al.
Publicado: (2023)

Clinical Lipid Control Success Rate Before and After Percutaneous Coronary Intervention in Iran; a Single Center Study
por: Hosseini, Seyed Kianoosh, et al.
Publicado: (2013)

Measurement of Atrial Septal Defect Size: A Comparative Study between Transesophageal Echocardiography and Balloon Occlusive Diameter Method
por: Sadeghian, Hakimeh, et al.
Publicado: (2010)

Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time
por: Spencer, Akpan, et al.
Publicado: (2011)

Falsely prolonged activated partial thromboplastin time – a pre- and post-analytical issue
por: Gils, Charlotte, et al.
Publicado: (2018)

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform
por: Katayama, Haruna, et al.
Publicado: (2018)

Effects of Enhanced External Counterpulsation on Heart Rate Recovery in Patients with Coronary Artery Disease
por: Sardari, Akram, et al.
Publicado: (2018)

Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery
por: Schneider, Christian P, et al.
Publicado: (2010)

A Patient with a Prolonged Activated Partial Thromboplastin Time and a Deep Intracerebral Haemorrhage
por: Schindhelm, Roger K., et al.
Publicado: (2012)

Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus
por: Sapkota, Binaya, et al.
Publicado: (2013)

Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients
por: Tokutake, Takayoshi, et al.
Publicado: (2016)

Prolonged activated partial thromboplastin time secondary to factor XII deficiency in two surgical patients
por: Moiz, Bushra, et al.
Publicado: (2021)

Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population
por: Zhang, Fan, et al.
Publicado: (2022)

Association of serum gamma-glutamyltransferase and premature coronary artery disease
por: Sheikh, M., et al.
Publicado: (2017)

Normalization of Activated Partial Thromboplastin Time Correlates with Low Levels of Dabigatran in a Patient with Severe Sepsis
por: Højland, Rikke Ebenhard, et al.
Publicado: (2015)

Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients
por: Bachler, Mirjam, et al.
Publicado: (2019)

Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?
por: Bronić, Ana, et al.
Publicado: (2021)

Anticoagulation in syncardia total artificial heart recipients: anti-factor Xa or activated partial thromboplastin time?
por: Monteagudo-Vela, María, et al.
Publicado: (2021)

The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma
por: Geng, Chuanying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e6k7qnm92o600fj68vjtmnk4t3